Abeona Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -70.6% | +65.9% | +91.7% | +563.6% | -16.5% | -23.5% | -39.4% | -6.1% | -35.0% | -10.9% | +42.4% | -54.4% | -62.0% | +454.1% | -56.8% | -54.3% | -64.6% | +2,605.1% | +382.8% | +38.7% | +61.0% | -2.4% | +28.1% | -32.3% | -47.4% | -19.3% | -0.3% | +70.2% | +101.6% | |
| – | -89.4% | +206.1% | -26.7% | +2,299.0% | -20.7% | -40.9% | -61.0% | -34.4% | +63.3% | -2.5% | +64.9% | -63.9% | -77.2% | +1,085.5% | -59.2% | -49.3% | -65.8% | +1,909.6% | +251.1% | +71.1% | +102.5% | -36.8% | +49.0% | -26.2% | -42.4% | -5.7% | +5.0% | +80.9% | +103.2% | |
| – | -90.1% | +242.5% | -40.0% | +835.0% | -11.8% | -80.6% | -49.7% | +144.2% | -80.3% | +242.1% | +479.6% | -61.3% | -77.3% | +1,058.6% | -65.0% | -83.9% | +7.1% | +2,617.0% | +248.4% | +72.3% | +99.2% | -86.4% | +589.4% | -90.3% | +161.5% | -56.8% | +1.8% | +61.4% | +235.8% | |
| – | -90.1% | +242.5% | -40.0% | +2,767.7% | -22.0% | -51.4% | -73.5% | -12.6% | -79.0% | +825.9% | +57.7% | -61.3% | -77.3% | +1,058.6% | -65.0% | -83.9% | +7.1% | +2,617.0% | +248.4% | +72.3% | +99.2% | -38.3% | +52.1% | -26.5% | -52.6% | +15.8% | +0.1% | +87.1% | +95.9% | |
| – | +0.0% | – | – | +347.0% | -56.8% | +559.6% | -3.7% | -93.7% | +5,728.6% | -92.0% | +169.1% | -84.8% | -75.5% | +2,727.8% | -67.3% | +152.3% | -91.2% | -52.7% | +228.6% | +7.8% | -13.7% | -24.3% | -100.0% | – | – | -93.7% | +1,200.0% | -32.4% | +306.5% | |
| – | – | – | – | – | – | – | -76.6% | +15.7% | +58.4% | – | – | – | – | – | – | +28.5% | -100.0% | – | – | -100.0% | – | – | – | – | – | +33,799,900.0% | – | – | – | |
| – | – | – | – | – | +311.2% | +55.6% | +35.3% | +3.6% | -71.2% | -29.3% | -38.7% | -33.1% | -42.5% | -36.0% | +59.4% | -86.3% | -14.3% | -33.3% | +8,650.0% | +106.0% | +90.6% | +587.3% | +39.3% | +39.5% | +18.5% | -49.1% | – | – | – | |
| – | – | – | – | – | -11.7% | +0.0% | +0.0% | +0.0% | – | – | – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -100.0% | – | – | – | – | |
| – | – | +39,900.0% | +725.0% | -9.0% | -12.0% | +30.2% | +42.1% | -34.4% | -65.0% | -19.4% | -21.4% | +40.7% | -21.2% | -27.1% | -36.9% | -100.0% | – | – | +32.4% | +26.9% | -52.6% | +982.3% | -15.9% | -95.9% | -7.7% | – | – | – | – | |
| – | -2.3% | -29.2% | +66.7% | +1,452.2% | +5.7% | +15.8% | -7.2% | +0.7% | -35.5% | +42.5% | -48.1% | +81.4% | +86.1% | +3.5% | -27.7% | -12.1% | -18.2% | -23.6% | +4.8% | -3.0% | -27.5% | +365.6% | +11.4% | +8.2% | -23.5% | +0.6% | +31.3% | +32.0% | -7.0% | |
| – | +4.6% | -29.2% | +100.0% | +99.2% | +21.0% | +97.8% | -24.2% | +192.1% | -63.9% | +183.5% | -81.0% | +269.9% | +13.4% | +65.1% | -14.5% | -45.6% | +35.2% | -67.7% | -49.0% | +461.7% | -32.4% | +263.0% | +90.1% | +8.4% | -60.4% | -53.2% | +72.5% | +23.6% | +78.3% | |
| – | +19.1% | -44.8% | -74.0% | – | – | +637.4% | -57.2% | +2,367.8% | -98.7% | +8,233.0% | -99.3% | +1,189.1% | – | – | -50.0% | +48.9% | – | – | -250.5% | – | – | – | -83.0% | +20.2% | -11.0% | -2.5% | -43.7% | +576.3% | +93.9% | |
| – | – | – | +75.0% | +65.4% | +28.3% | +66.2% | -27.9% | -2.9% | +66.8% | -57.5% | +22.8% | +118.3% | +24.6% | -27.1% | -42.6% | +19.0% | -57.7% | +119.7% | -53.9% | +322.2% | -49.1% | +225.5% | -38.5% | +24.8% | -7.9% | -58.1% | +2.6% | +85.2% | +129.3% | |
| – | – | – | – | – | +3.5% | -0.8% | -0.5% | -58.8% | +34.1% | -28.0% | +0.0% | +0.0% | +0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -40.1% | |
| – | -85.2% | +200.5% | +100.0% | +316.8% | -39.5% | -94.6% | -1,291.2% | – | – | – | – | -1,742.6% | – | – | – | – | – | – | +1,306.2% | +46.3% | +71.6% | -21.2% | +33.1% | -42.5% | -58.7% | -36.8% | -44.6% | +197.0% | +261.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +37.0% | +77.7% | +81.3% | +16.5% | +1.9% | +1.2% | +14.3% | +6.8% | +9.1% | +0.6% | +135.2% | +41.5% | +32.3% | +27.8% | +21.0% | +5.4% | -4.7% | +5,582.2% | +23.8% | +21.8% | +14.2% | +5.9% | +84.1% | +6.2% | +99.6% | +171.9% | +92.0% | +61.1% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.